← Back to Search

Text Messaging Support for Post-Emergency Care Assistance Programs (LEAP Trial)

N/A

Waitlist Available

Led By Austin Kilaru, MD, MSHP

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14 days post-discharge from the emergency department

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if sending texts to patients after hospital discharge helps them get enrolled in public benefits programs.

Who is the study for?

Adults over 18 living in Philadelphia, visiting Penn Medicine Emergency Departments without needing hospitalization. They must speak/read English, have Medicaid/Medicare or no insurance, be eligible for public benefits programs, and have a stable mobile phone number for at least three weeks.

What is being tested?

The study is testing if text messages can help connect emergency department patients to public benefits by comparing the effectiveness of texts plus a flyer with just the flyer alone. The main measures are calls made to Benefits Data Trust and applications submitted.

What are the potential side effects?

Since this trial involves text messaging interventions rather than medical treatments, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14 days post-discharge from the emergency department

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14 days post-discharge from the emergency department

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days post-discharge from the emergency department for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Participant Connection to BDT

Secondary study objectives

Number of Applications Submitted

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Participants in the intervention arm will receive a summary flyer providing contact information for benefits enrollment navigators at BenePhilly and will be instructed that study personnel will contact them one-day post-discharge to help connect them to a BDT enrollment navigator to help them submit their applications for public benefits. At Day 1 post-discharge, participants in the intervention group will receive a text message to prompt them to call the BDT enrollment navigators to complete their applications for public benefits they screened for while in the ED. On Day 3, patients will receive a follow-up message to assess whether they have contacted BDT. Those participants who indicate they have not yet connected with BDT on Day 3 will receive reminder text messages at Day 7 and 14 post-discharge.

Group II: Active ControlActive Control1 Intervention

Participants in the control group will receive a summary flyer providing contact information for benefits enrollment navigators at BenePhilly, which includes a unique study phone line provided by Benefits Data Trust. Currently, the standard of care is for ED patients to receive no information about public benefits. Therefore, the flyer represents an augmentation of usual care for patients randomized to the control group.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Text Messaging Intervention

2011

N/A

~860

Do I qualify?Apply below to find out